Related Experiment Video
Updated: Jul 17, 2025
09:49
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
3.4K
Botanical drugs for treating erectile dysfunction: clinical evidence
Dengjianyi Xu1, Yucong Zhang2, Jian Bai3
1Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Frontiers in Pharmacology
|September 1, 2023
Summary
Botanical drugs show promise for treating erectile dysfunction (ED), offering potential alternatives to phosphodiesterase-5 inhibitors (PDE5-i). Further research is needed to confirm efficacy and identify active compounds for new ED treatments.
Area of Science:
- Pharmacology
- Urology
- Herbal Medicine
Background:
- Phosphodiesterase-5 inhibitors (PDE5-i) are common erectile dysfunction (ED) treatments.
- Suboptimal effects and side effects necessitate novel ED therapeutic strategies.
Purpose of the Study:
- To review botanical drugs investigated for erectile dysfunction (ED) treatment.
- To summarize clinical findings and mechanisms of action for botanical ED therapies.
Main Methods:
- Systematic review of 34 studies on botanical drugs for ED.
- Categorization of botanical drugs based on PDE5 inhibitory activity (five with, seven without, six mixed).
Main Results:
- Botanical drugs demonstrate promising therapeutic effects for ED.
- Clinical study results and mechanisms of action for various botanical agents were summarized.
Conclusions:
- Botanical drugs represent a potential avenue for ED treatment.
- High-quality clinical trials are required to validate dosage, patient targeting, and efficacy.
- Further pharmacological studies are needed to isolate active compounds.
Related Concept Videos
01:20Disorders of the Male Reproductive System
453
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
453
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
186
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
186
01:17Male Sexual Response: Erection & Ejaculation
2.7K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
2.7K
01:22Dose-Response Relationship: Potency and Efficacy
4.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.5K
01:23Antihypertensive Drugs: Vasodilators
566
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
566
01:16Antianginal Drugs: Nitrates and β-Blockers
640
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
640